Treatment for Acute Bronchitis
Antibiotics should not be prescribed for acute bronchitis in otherwise healthy adults, regardless of cough duration or sputum color, because the illness is viral in 89-95% of cases and antibiotics shorten cough by only half a day while causing significant adverse effects. 1, 2
Initial Assessment: Rule Out Pneumonia First
Before diagnosing acute bronchitis, you must exclude pneumonia by checking vital signs and performing a focused chest examination. 1, 3
Obtain a chest X-ray if ANY of the following are present: 1, 3
- Heart rate >100 beats/min
- Respiratory rate >24 breaths/min
- Oral temperature >38°C
- Abnormal lung findings (crackles, egophony, increased tactile fremitus)
If all four criteria are absent in patients <70 years without comorbidities, pneumonia is unlikely and chest radiography is not needed. 1
Why Antibiotics Don't Work
The evidence against antibiotics is compelling:
- Viral etiology: Respiratory viruses cause 89-95% of acute bronchitis cases 1, 2
- Minimal benefit: Antibiotics reduce cough duration by only 0.5 days (approximately 12 hours) 1, 4
- Increased harm: Antibiotics increase adverse events with a relative risk of 1.20 (95% CI 1.05-1.36), including diarrhea, rash, and yeast infections 1
Common pitfall: Purulent (green/yellow) sputum occurs in 89-95% of viral bronchitis cases and does NOT indicate bacterial infection—it reflects inflammatory cells, not bacteria. 1, 5
Appropriate Symptomatic Management
For Bothersome Cough
- Antitussives (codeine or dextromethorphan) provide modest relief, especially for dry cough that disrupts sleep 1, 3
For Wheezing Only
- Short-acting β₂-agonists (albuterol) should be used ONLY in patients with accompanying wheezing 1, 3
- Do not use bronchodilators routinely in the absence of wheeze 1
Environmental Measures
- Remove irritants (dust, allergens) and use humidified air 1
What NOT to Use
Avoid the following—they lack evidence of benefit: 1, 3
- Expectorants or mucolytics
- Antihistamines
- Inhaled or oral corticosteroids
- NSAIDs at anti-inflammatory doses
- Inhaled anticholinergics
The Pertussis Exception
If pertussis is confirmed or strongly suspected (paroxysmal cough, post-tussive vomiting, inspiratory "whoop," cough >2 weeks), prescribe a macrolide antibiotic (azithromycin or erythromycin) immediately and isolate the patient for 5 days from treatment start. 1
Early macrolide therapy reduces cough paroxysms and prevents disease spread. 1
Essential Patient Education
Set realistic expectations about illness duration: 1, 3
- Cough typically lasts 10-14 days after the visit
- Cough may persist up to 3 weeks even without treatment
- The condition is self-limiting and viral
Explain why antibiotics are being withheld: 1
- Antibiotics do not shorten the illness
- They expose patients to side effects (diarrhea, rash, yeast infections)
- Previous antibiotic use increases carriage of resistant bacteria
Communication matters more than prescriptions: Patient satisfaction depends more on clear physician-patient communication than whether an antibiotic is prescribed. 1
Terminology tip: Referring to the illness as a "chest cold" rather than "bronchitis" reduces patient expectations for antibiotics. 1
When to Reassess
Advise patients to return if: 1, 3
- Fever persists >3 days (suggests bacterial superinfection or pneumonia)
- Cough persists >3 weeks (consider asthma, COPD, pertussis, GERD)
- Symptoms worsen rather than gradually improve
Consider Alternative Diagnoses
Approximately one-third of patients with "recurrent acute bronchitis" actually have undiagnosed asthma or COPD. 1
Perform spirometry or peak-flow testing if: 1
- Patient smokes or has other risk factors
- Recurrent episodes occur
- Cough worsens at night or with exercise
A ≥12% and ≥200 mL increase in FEV₁ after bronchodilator (or ≥20% peak-flow improvement) confirms reversible airway disease. 1
Special Populations (Different Management)
These recommendations apply ONLY to otherwise healthy adults. The following groups require individualized management and may need antibiotics: 1
- Patients ≥75 years with fever and comorbidities (heart failure, insulin-dependent diabetes, serious neurologic disease)
- Chronic lung disease (COPD, chronic bronchitis, bronchiectasis, cystic fibrosis)
- Immunosuppressed patients
- Patients with cardiac failure
For COPD exacerbations, antibiotics are considered when at least two of the three Anthonisen criteria are met: increased dyspnea, increased sputum volume, and increased sputum purulence. 1